Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name PCAT7
   Synonyms PCAT7, PCAN-R2
   Region GRCh38_9:94555054-94603990    Sequence
   Ensembl ENSG00000231806
   RefSeq NR_121566
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name nasopharyngeal cancer
   ICD-0-3 C11  
   Methods qPCR, Western blot, Luciferase reporter assay, RNAi etc.
   Sample Nasopharyngeal Carcinoma cell lines (SUNE-1, CNE-1, HNE-1, CNE2, C666-1, HONE-1), Nasopharyngeal Carcinoma tissues
   Expression Pattern up-regulated
   Function Description

Relative expression of PCAT7 expression in NPC cell lines and normal oral epidermal cell. Here, we discovered the novel LncRNA, prostate cancer associated transcript 7 (PCAT7), which was overexpressed and associated with worse prognosis in NPC. Decreased PCAT7 expression was found to significantly suppress tumor cell proliferation in vitro, and inhibited tumor growth and reduced the expression of proliferation antigen Ki67 in vivo. Rescue assay was performed to further confirm that PCAT7 contributed to the progression of NPC through regulating miR-134-5p/ELF2 signal pathway. .The Kaplan-Meier survival analysis indicated that PCAT7 high expression (red line, n=38) has a worse overall survival compared to the low expression subgroup (grey line, n=12)hese results indicated that PCAT7 might contribute to the tumor progression in NPC by functioning as a ceRNA to sponge miR-134-5p.

   Pubmed ID 28728844
   Year 2017
   Title Long non-coding RNA PCAT7 regulates ELF2 signaling through inhibition of miR-134-5p in nasopharyngeal carcinoma.
   External Links
   Links for  PCAT7 GenBank       HGNC       lncrnadb       Noncode
   Links for  nasopharyngeal cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.